Viewing Study NCT06460701



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06460701
Status: RECRUITING
Last Update Posted: 2024-07-10
First Post: 2024-06-11

Brief Title: Effects of m-CIMT With and Without Kinesiotaping for Children With Erbs Palsy
Sponsor: Riphah International University
Organization: Riphah International University

Study Overview

Official Title: Effects of Modified Constraint Induced Movement Therapy With and Without Kinesiotaping for Children With Erbs Palsy
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The upper brachial plexus a network of nerves in the neck and shoulder is affected by Erbs palsy often referred to as Erb-Duchenne palsy This syndrome usually arises after labor particularly if the babys head and neck are pulled or stretched excessively during delivery Erbs palsy can cause the hand and arm on the afflicted side of the body to become paralyzed or feeble Erbs palsy symptoms can include restricted range of motion in the injured arm weakened hand and arm in the afflicted area loss of feeling in the hand or arm The effected arm is in waiters tip position in which the elbow is bent and the wrist is flexed The purpose of this research is to evaluate the effectiveness of modified constraint-induced movement therapy in children with erbs palsy both with and without kinesiotaping

Convenient sampling will be the method of sampling and the study design will be randomized control trial There will be two groups created with n 40 subjects each Twenty participants will be divided into two groups twenty for each group will receive modified constraint-induced movement therapy plus kinesiotaping while twenty for the other group will receive modified constraint-induced movement therapy alone The youngsters will be evaluated using the Active Movement ScaleBoth at the programs baseline and after the intervention is over data will be gathered The course of treatment will run for eight weeks straight meeting three times a week for an hour each time Based on inclusion criteria subjects from Ayesha Amir Memorial Hospital and Children Hospital Faisalabad will be chosen Data analysis will be done using SPSS 2500
Detailed Description: Group A will be applied modified constraint induced movement therapy session will last for one hour including following exercises such as ROM with the sling Flexion extension abduction and rotation of the shoulder Flexion and extension of the elbow Supination of forearm-Extension of wrist and finger Stretching exercises for internal rotators adductors extensors of shoulder This will reduce the tightness and enhance the range of movement Strengthening exercises also be applied to this group by throwing a ball in different directions above head position by drawing on paper stuck on the wall or window at different heights by supinating bottles weighing 500g as tolerated by the child by thera band exercises above across and below the chest Repetitive movement such as supinating the light bottles Functional activities including some playful movement will be done by this group in which children are involved in different activities eg playing with toys blocks and such objects Additionally this group will engaged in a kinesiotaping program which aims to obtain more stability to the scapula on the affected side through facilitating middle and lower trapezius function The shoulders will be kept in downward and back- ward position while the alignment of scapulae should be manually maintained during the tape application KT will set medially at the spinous processes T2-T3 for middle trapezius and T12 for lower trapezius and will be applied toward the acromion

Group B will undergo same intervention such as group A alongwith m-CIMT but without the application of kinesiotaping

There will be three sessions per week for the eight consecutive weeks

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None